Your browser doesn't support javascript.
loading
Vitamin D status in pregnancy and cord blood is associated with symptoms of attention-deficit hyperactivity disorder at age 5 years: Results from Odense Child Cohort.
Thinggaard, Camilla Munk; Dalgård, Christine; Möller, Sören; Christesen, Henrik Boye Thybo; Bilenberg, Niels.
Affiliation
  • Thinggaard CM; Department of Child and Adolescent Psychiatry, Mental Health Hospital and University Clinic, Region of Southern Denmark, Odense, Denmark.
  • Dalgård C; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Möller S; Acute and Medical Department, Aalborg University Hospital, Thisted, Denmark.
  • Christesen HBT; Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
  • Bilenberg N; Research Unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Aust N Z J Psychiatry ; : 48674241272018, 2024 Aug 16.
Article in En | MEDLINE | ID: mdl-39152569
ABSTRACT

BACKGROUND:

Vitamin D status in pregnancy may affect offspring neurodevelopment.

OBJECTIVE:

The objective was to investigate the association between serum 25-hydroxyvitamin D in cord blood and pregnancy and symptoms of attention-deficit hyperactivity disorder in 5-year-old offspring.

METHOD:

In Odense Child Cohort, Denmark, 944 mother-child pairs had data on pregnancy or cord serum 25-hydroxyvitamin D and parent-rated attention-deficit hyperactivity disorder symptom score by Child Behavior Checklist for ages 1.5-5 years. Adjusted multiple linear regression and two-stage exposure analyses were performed for serum 25-hydroxyvitamin D associations to the attention-deficit hyperactivity disorder symptom score.

RESULTS:

The mean (standard deviation) serum 25-hydroxyvitamin D in cord blood was 48.0 (21.8) nmol/L; early pregnancy was 65.5 (20.2) nmol/L and late pregnancy was 79.3 (25.7) nmol/L. The median (interquartile range) age of child at examination was 5.2 (5.1-5.4) years and median (interquartile range) attention-deficit hyperactivity disorder symptom score was 2 (0-3) points. In adjusted analyses, serum 25-hydroxyvitamin D of <25 nmol/L and <32 nmol/L in cord blood and <25 nmol/L in early pregnancy was associated with 0.9 [95% confidence interval 0.4, 1.3], 0.5 [0.1, 0.9] and 2.1 [0.8, 3.4] points higher attention-deficit hyperactivity disorder symptom score vs reference. In the two-stage exposure analysis, attention-deficit hyperactivity disorder symptom score decreased by 0.4 points per 25 nmol/L increase in serum 25-hydroxyvitamin D. Moreover, serum 25-hydroxyvitamin D of <25 nmol/L in early pregnancy and cord was associated with a five-fold and a two-fold risk of attention-deficit hyperactivity disorder symptom score ⩾90th percentile, adjusted odds ratio [95% confidence interval] = 4.9 [1.3, 19.0] and 2.2 [1.2, 3.9].

CONCLUSION:

In this cohort, serum 25-hydroxyvitamin D <25 nmol/L in cord blood and early pregnancy were risk factors for higher attention-deficit hyperactivity disorder symptom score in 5-year-old children, suggesting a protective effect of vitamin D on attention-deficit hyperactivity disorder traits at preschool age.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Aust N Z J Psychiatry Year: 2024 Document type: Article Affiliation country: Dinamarca Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Aust N Z J Psychiatry Year: 2024 Document type: Article Affiliation country: Dinamarca Country of publication: Reino Unido